NCT01976754View on ClinicalTrials.gov

Safety Study of Dexmedetomidine in Septic Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions
SepsisAgitation
Interventions
DRUG

Dexmedetomidine

Septic patients are randomly received 1 of 6 doses( 0.2,0.3,0.4,0.5,0.6,0.7μg/kg/h) dexmedetomidine.

Trial Locations (1)

310000

Zhanqin Zhang, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT01976754 - Safety Study of Dexmedetomidine in Septic Patients | Biotech Hunter | Biotech Hunter